Multiple Sclerosis : : Diagnosis and Treatment / / Víctor M. Rivera.
Multiple sclerosis (MS) offers important challenges to understanding its complex genetics and molecular and immunological mechanisms, which eventually lead to relapsing and progressive clinical forms and a constellation of clinical manifestations. Along with the progress in knowledge, disease-modify...
Saved in:
VerfasserIn: | |
---|---|
Place / Publishing House: | Basel : : MDPI - Multidisciplinary Digital Publishing Institute,, 2022. |
Year of Publication: | 2022 |
Language: | English |
Physical Description: | 1 online resource (192 pages) |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
993562233304498 |
---|---|
ctrlnum |
(CKB)4920000001372175 (NjHacI)994920000001372175 (EXLCZ)994920000001372175 |
collection |
bib_alma |
record_format |
marc |
spelling |
Rivera, Víctor M, author. Multiple Sclerosis : Diagnosis and Treatment / Víctor M. Rivera. Multiple Sclerosis Basel : MDPI - Multidisciplinary Digital Publishing Institute, 2022. 1 online resource (192 pages) text txt rdacontent computer c rdamedia online resource cr rdacarrier Description based on publisher supplied metadata and other sources. Multiple sclerosis (MS) offers important challenges to understanding its complex genetics and molecular and immunological mechanisms, which eventually lead to relapsing and progressive clinical forms and a constellation of clinical manifestations. Along with the progress in knowledge, disease-modifying treatments and new therapeutic molecules have made an impact on the prognosis of the disease. Essential in the diagnostic identification process of MS is the differentiation of this major demyelinating disease with other inflammatory CNS disorders, including Neuromyelitis Optica and MOG antibody disease. MS is more prevalent in women; therefore, pregnancy and post-partum hormonal and immunological changes typically affect the clinical behavior of the disease. This Special Issue of Biomedicines addresses recent advances in the mechanistic genetic and immunological processes of MS, opening more options to future studies and to the consideration of further therapeutic possibilities. The issue discusses the application of modern therapies, including monoclonal antibodies, some still in the process of complete development, and the current strategies managing progressive MS. The aim of this issue is to stimulate basic and clinical research and promote observations on the ever-expanding and complex field of MS. Advancement in the understanding of the mechanisms and the clinical characterizations of this disease should result in improved therapeutic outcomes that reduce neurological and cognitive disability commonly associated with progressive disease. Medicine. 3-0365-3097-5 |
language |
English |
format |
eBook |
author |
Rivera, Víctor M, |
spellingShingle |
Rivera, Víctor M, Multiple Sclerosis : Diagnosis and Treatment / |
author_facet |
Rivera, Víctor M, |
author_variant |
v m r vm vmr |
author_role |
VerfasserIn |
author_sort |
Rivera, Víctor M, |
title |
Multiple Sclerosis : Diagnosis and Treatment / |
title_sub |
Diagnosis and Treatment / |
title_full |
Multiple Sclerosis : Diagnosis and Treatment / Víctor M. Rivera. |
title_fullStr |
Multiple Sclerosis : Diagnosis and Treatment / Víctor M. Rivera. |
title_full_unstemmed |
Multiple Sclerosis : Diagnosis and Treatment / Víctor M. Rivera. |
title_auth |
Multiple Sclerosis : Diagnosis and Treatment / |
title_alt |
Multiple Sclerosis |
title_new |
Multiple Sclerosis : |
title_sort |
multiple sclerosis : diagnosis and treatment / |
publisher |
MDPI - Multidisciplinary Digital Publishing Institute, |
publishDate |
2022 |
physical |
1 online resource (192 pages) |
isbn |
3-0365-3097-5 |
callnumber-first |
R - Medicine |
callnumber-subject |
R - General Medicine |
callnumber-label |
R117 |
callnumber-sort |
R 3117 R584 42022 |
illustrated |
Not Illustrated |
dewey-hundreds |
600 - Technology |
dewey-tens |
610 - Medicine & health |
dewey-ones |
610 - Medicine & health |
dewey-full |
610 |
dewey-sort |
3610 |
dewey-raw |
610 |
dewey-search |
610 |
work_keys_str_mv |
AT riveravictorm multiplesclerosisdiagnosisandtreatment AT riveravictorm multiplesclerosis |
status_str |
n |
ids_txt_mv |
(CKB)4920000001372175 (NjHacI)994920000001372175 (EXLCZ)994920000001372175 |
carrierType_str_mv |
cr |
is_hierarchy_title |
Multiple Sclerosis : Diagnosis and Treatment / |
_version_ |
1764992751686909952 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02516nam a2200289 i 4500</leader><controlfield tag="001">993562233304498</controlfield><controlfield tag="005">20230225162900.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr |||||||||||</controlfield><controlfield tag="008">230225s2022 sz o 000 0 eng d</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.3390/books978-3-0365-3097-0</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)4920000001372175</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(NjHacI)994920000001372175</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)994920000001372175</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">NjHacI</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="c">NjHacl</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">R117</subfield><subfield code="b">.R584 2022</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="2">23</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Rivera, Víctor M,</subfield><subfield code="e">author.</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Multiple Sclerosis :</subfield><subfield code="b">Diagnosis and Treatment /</subfield><subfield code="c">Víctor M. Rivera.</subfield></datafield><datafield tag="246" ind1=" " ind2=" "><subfield code="a">Multiple Sclerosis </subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Basel :</subfield><subfield code="b">MDPI - Multidisciplinary Digital Publishing Institute,</subfield><subfield code="c">2022.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (192 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on publisher supplied metadata and other sources.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Multiple sclerosis (MS) offers important challenges to understanding its complex genetics and molecular and immunological mechanisms, which eventually lead to relapsing and progressive clinical forms and a constellation of clinical manifestations. Along with the progress in knowledge, disease-modifying treatments and new therapeutic molecules have made an impact on the prognosis of the disease. Essential in the diagnostic identification process of MS is the differentiation of this major demyelinating disease with other inflammatory CNS disorders, including Neuromyelitis Optica and MOG antibody disease. MS is more prevalent in women; therefore, pregnancy and post-partum hormonal and immunological changes typically affect the clinical behavior of the disease. This Special Issue of Biomedicines addresses recent advances in the mechanistic genetic and immunological processes of MS, opening more options to future studies and to the consideration of further therapeutic possibilities. The issue discusses the application of modern therapies, including monoclonal antibodies, some still in the process of complete development, and the current strategies managing progressive MS. The aim of this issue is to stimulate basic and clinical research and promote observations on the ever-expanding and complex field of MS. Advancement in the understanding of the mechanisms and the clinical characterizations of this disease should result in improved therapeutic outcomes that reduce neurological and cognitive disability commonly associated with progressive disease.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Medicine.</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-0365-3097-5</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-03-01 01:53:44 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2022-09-22 08:09:39 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5338185000004498&Force_direct=true</subfield><subfield code="Z">5338185000004498</subfield><subfield code="8">5338185000004498</subfield></datafield></record></collection> |